Brief: Candel Therapeutics Appoints Charles Schoch As Chief Financial Officer
23/06/2025 13:20
June 23 (Reuters) - Candel Therapeutics Inc CADL.O: CANDEL THERAPEUTICS APPOINTS CHARLES SCHOCH AS CHIEF FINANCIAL OFFICER Source text: ID:nGNX99lG2p Further company coverage: CADL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)